检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:唐瑞峰[1] 张志明[1] 马景枝[2] 李智峰[1] 苑建磊[1] 齐帅[1] 田贵金[1] 孙朝[1]
机构地区:[1]河北医科大学第四医院肝胆外科,河北石家庄050011 [2]河北医科大学第四医院检验科,河北石家庄050011
出 处:《临床荟萃》2007年第18期1311-1314,F0003,共5页Clinical Focus
基 金:河北省科学技术研究与发展计划项目(编号:062761317)
摘 要:目的探讨肝细胞肝癌(HCC)中血管内皮生长因子D(VEGF-D)及其受体flt-4的表达以及与肝癌临床病理特征如淋巴结转移之间的关系。方法应用免疫组织化学染色法检测48例HCC、28例癌旁组织及12例正常肝组织中VEGF-D的表达及flt-4阳性淋巴管的计数,分析VEGF-D的表达与肝癌临床病理特征的关系。结果HCC中VEGF-D的表达显著高于癌旁和正常肝组织,分别为75.0%(36/48),50.0%(14/28)和41.7%(5/12)(P<0.01);VEGF-D的表达与肝癌淋巴结转移和临床分期呈正相关(P<0.05);VEGF-D及flt-4在有肝门淋巴结转移组中的表达明显高于无淋巴转移组(P<0.05);VEGF-D及其受体flt-4在肝癌组织中的表达具有明显的相关性(P<0.05)。结论VEGF-D及其受体flt-4在肝癌组织中呈高表达,并与肝癌的淋巴结转移密切相关。Objective To study the expression of vascular endothelial growth factor D(VEGF-D) and its receptor flt-4 in hepatocellular carcinoma(HCC) tissue and to determine whether the expressions of VEGF-D and flt-4 were associated with clinical pathologic characters. Methods The expressions of VEGF-D and flt-4 proteins were examined by immunohistochemistry in 48 HCC tissues and 28 adjancent tumor tissues and 12 normal tissues,and the correlation between VEGF-D expression and clinical pathologic character was analyzed. Results Imunohistochemical analysis revealed that expression of VEGF-D was higher in HCC tissue than that of adjancent tumor tissues and normal tissues, respectively 75.0 % (36/48), 50.0 %(14/28) and 41.7 %(5/12)( P 〈0.01). The expression of VEGF-D was associated with lymph node metastasis and clinical stage (P 〈0.05). The expressions of VEGF-D and flt-4 in lymphatic metastasis group were higher than those of no lymphatic metastasis group( P 〈0.05) and there was a distinct relativity between the expression of VEGF-D and expression of flt-4 in HCC. Conclusion VEGF-D and fit-4 are commonly overexDressed in HCC and may contribute to lymph node metastasis.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.30